When to Start Metformin in GDM
Metformin should NOT be used as first-line therapy for gestational diabetes mellitus—insulin is the preferred medication. If metformin is considered, it should only be initiated after the first trimester (after 13 weeks gestation) in women who fail medical nutrition therapy and exercise, and only when they refuse or cannot use insulin 1, 2, 3.
Treatment Algorithm for GDM
Step 1: Initial Management (All Patients)
- Begin with medical nutrition therapy and exercise immediately upon GDM diagnosis
- Target fasting glucose <95 mg/dL (5.3 mmol/L) and 1-hour postprandial <140 mg/dL (7.8 mmol/L)
- Continue lifestyle modifications for 1 week before considering pharmacotherapy 4
Step 2: When to Add Pharmacotherapy
Add medication if glycemic targets are not achieved after 1 week of lifestyle intervention 4.
Step 3: Choice of Medication
Insulin is preferred in ALL cases 1, 3. The 2023 American Diabetes Association guidelines explicitly state that metformin should not be used as a first-line agent because it crosses the placenta to the fetus 1.
Metformin may be considered ONLY when:
- Patient is beyond first trimester (>13 weeks gestation) 4
- Patient refuses insulin or cannot use it 4
- Patient is not using glyburide 4
- Fasting plasma glucose is <110 mg/dL (6.1 mmol/L) 4
- GDM diagnosis occurred at ≥25 weeks gestation 4
Critical Timing Considerations
First Trimester Restriction
Metformin must be avoided or discontinued in the first trimester 1, 2. If a woman is taking metformin for polycystic ovary syndrome to induce ovulation, it should be discontinued by the end of the first trimester 1.
Gestational Age at Diagnosis
The 2013 Endocrine Society guidelines specifically recommend against metformin when GDM is diagnosed before 25 weeks gestation—these patients should receive insulin 4.
Important Caveats and Pitfalls
Placental Transfer and Long-Term Concerns
The most recent 2025 Endocrine Society/European Society of Endocrinology joint guideline raises significant concerns about metformin use in pregnancy 5. Metformin crosses the placenta readily, achieving fetal levels equal to or higher than maternal levels 6, 3. Studies in primates showed metformin bioaccumulates in fetal kidneys and liver, decreases fetal weight and skeletal muscle mass 5.
Offspring Metabolic Effects
Multiple follow-up studies demonstrate concerning trends:
- 9-year-old children exposed to metformin in utero had higher weight, waist circumference, and waist-to-height ratios in some cohorts 6, 3
- 4-10 year follow-up studies showed higher BMI and increased childhood obesity 6, 3
- Meta-analyses indicate metformin exposure results in smaller neonates with accelerated postnatal growth and higher childhood BMI 6
Treatment Failure Rates
Approximately 14-46% of women started on metformin will require supplemental insulin to achieve adequate glycemic control 3, 7. Women more likely to fail metformin therapy include those with:
- Higher obesity (BMI >36 kg/m²)
- Higher fasting glucose levels (>6.1 mmol/L)
- Earlier need for pharmacotherapy (<26 weeks gestation) 8
Contraindications in Type 2 Diabetes
For women with pre-existing type 2 diabetes (not GDM), the 2025 guidelines recommend against routine addition of metformin to insulin 5. These women have more severe insulin deficiency and resistance, requiring insulin as primary therapy.
Practical Dosing When Metformin Is Used
If metformin is initiated (after first trimester, meeting all criteria above):
- Start with 500 mg daily with meals
- Titrate by 500 mg weekly based on glucose response
- Maximum dose: 2500 mg/day 4
- Take with meals to minimize gastrointestinal side effects
Monitor closely for treatment failure—if glycemic targets are not achieved within 2-4 weeks, add insulin rather than continuing metformin alone 3.